Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac Expands Formulation Development Services | Contract Pharma
Breaking News

Almac Expands Formulation Development Services

Opens non-GMP facility and two analytical labs at UK headquarters

Almac has expanded its pharmaceutical development service offering with an investment of more than $10 million. The company has doubled its development service capabilities with the opening of a new dedicated non-GMP facility and two analytical laboratories at its UK headquarters. 
 
The new non-GMP formulation development facility offers formulation and process development, which can then be progressed and transferred to the existing GMP development facility located on the same campus. Almac has also doubled its analytical capacity with new analytical labs for processing the large sample sets from non-GMP process development work for clients looking to better understand their processes in line with the principles of QbD. Almac has also invested in additional Xcelodose technology, which comes with an Xcelohood providing the capability to dose potent API directly into capsules. 
 
“Almac is continually assessing and investing in solutions to accelerate the manufacturing of our client’s clinical supplies, while ensuring quality at all times. The investments this year in the new non-GMP facility and Xcelodose equipment strengthens Almac’s position as an integrated service provider in the pharmaceutical development sector,” said John McQuaid, vice president of Technical Operations.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters